A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer | MicrobiomeTrials← Back to trialsNCT05599685
A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer
CompletedOBSERVATIONAL
Trial Details
Start: 2022-10-19Est. Completion: 2025-09-16
Enrollment target: 302 participants Locations- Local Institution - 0001, Athens, Greece
Other microbiome trials you might be interested in
Non Squamous Non Small Cell Lung Cancer
This is a randomized, multicenter, multinational, double-blind, integrated pharmacokinetics (PK) and efficacy similarity…
Yerevan, ArmeniaEst. completion Aug 31, 2026
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
This phase II trial tests how well biologically guided radiation therapy (BgRT) and stereotactic body radiation therapy …
Duarte, United StatesCompleted Mar 9, 2027
Epidermal Growth FactorEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Gene MutationNon Small CellNon Small Cell LungNon Small Cell Lung CancerHead and NeckHead and Neck CancerHead and Neck CancersHead and Neck Squamous Cell CancerHead and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma HNSCCNSCLC (Non-small Cell Lung Cancer)HNSCCEGFR
A phase 1 study to determine the safety, tolerability, PK, PD, and preliminary anti-tumor activity of ascending doses of…
Los Angeles, United StatesEst. completion Jul 2029